Erik Skjelbo

1.4k total citations
17 papers, 1.1k citations indexed

About

Erik Skjelbo is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Erik Skjelbo has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 5 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Erik Skjelbo's work include Pharmacogenetics and Drug Metabolism (11 papers), Plant-based Medicinal Research (3 papers) and Analytical Chemistry and Chromatography (2 papers). Erik Skjelbo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Plant-based Medicinal Research (3 papers) and Analytical Chemistry and Chromatography (2 papers). Erik Skjelbo collaborates with scholars based in Denmark, Tanzania and United Kingdom. Erik Skjelbo's co-authors include Kim Brøsen, Birgitte Buur Rasmussen, Steffen Loft, Henrik E. Poulsen, Lars F. Gram, Jesper Hallas, Søren H. Sindrup, LF Gram, Nuala A. Helsby and Stephen A. Ward and has published in prestigious journals such as The Lancet, Methods in enzymology on CD-ROM/Methods in enzymology and Biochemical Pharmacology.

In The Last Decade

Erik Skjelbo

16 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Skjelbo Denmark	12	748	322	276	239	177	17	1.1k
H.K. Crewe United Kingdom	12	717 1.0×	319 1.0×	346 1.3×	163 0.7×	103 0.6×	14	1.2k
MS Lennard United Kingdom	18	714 1.0×	363 1.1×	250 0.9×	223 0.9×	148 0.8×	30	1.3k
Peter J. Wedlund United States	17	763 1.0×	203 0.6×	231 0.8×	415 1.7×	276 1.6×	39	1.4k
K. Br�sen Denmark	11	478 0.6×	242 0.8×	220 0.8×	152 0.6×	157 0.9×	13	915
S V Otton Canada	22	1.1k 1.5×	345 1.1×	403 1.5×	166 0.7×	248 1.4×	30	1.8k
J. Brockmöller Germany	7	778 1.0×	250 0.8×	230 0.8×	256 1.1×	252 1.4×	9	1.1k
P Bechtel France	15	495 0.7×	198 0.6×	201 0.7×	126 0.5×	110 0.6×	55	935
Lisa L. von Moltke United States	19	1.2k 1.6×	388 1.2×	596 2.2×	263 1.1×	296 1.7×	22	2.0k
W Kalow Canada	17	668 0.9×	177 0.5×	306 1.1×	90 0.4×	168 0.9×	35	1.1k
P J Wedlund United States	19	737 1.0×	137 0.4×	336 1.2×	217 0.9×	250 1.4×	31	1.2k

Countries citing papers authored by Erik Skjelbo

Since Specialization

Citations

This map shows the geographic impact of Erik Skjelbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Skjelbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Skjelbo more than expected).

Fields of papers citing papers by Erik Skjelbo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Skjelbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Skjelbo. The network helps show where Erik Skjelbo may publish in the future.

Co-authorship network of co-authors of Erik Skjelbo

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Skjelbo. A scholar is included among the top collaborators of Erik Skjelbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Skjelbo. Erik Skjelbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pedersen, Andreas James Thestrup & Erik Skjelbo. (2008). [Anemia--prevalence and etiology among acutely admitted geriatric patients].. PubMed. 170(17). 1453–7. 3 indexed citations

Rosholm, Jens‐Ulrik, Hanne Nybo, Karen Andersen‐Ranberg, et al.. (2002). Hyponatraemia in Very Old Nonhospitalised People. Drugs & Aging. 19(9). 685–693. 14 indexed citations

Bathum, Lise, Erik Skjelbo, Theonest K. Mutabingwa, et al.. (1999). Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. British Journal of Clinical Pharmacology. 48(3). 395–401. 45 indexed citations

Skjelbo, Erik & Kim Brøsen. (1998). [Interaction between paroxetine and clomipramine as a possible reason for admission to a department of internal medicine].. PubMed. 160(39). 5665–6. 1 indexed citations

Larsen, John, Erik Skjelbo, & Lars F. Gram. (1997). Helicobacter pylori infection. The Lancet. 349(9055). 878–879. 2 indexed citations

Skjelbo, Erik, Theonest K. Mutabingwa, Ib Christian Bygbjerg, et al.. (1996). Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians*. Clinical Pharmacology & Therapeutics. 59(3). 304–311. 42 indexed citations

Brøsen, Kim, Erik Skjelbo, & Karin Kramer Nielsen. (1996). [20] Imipramine: A model drug for P450 research. Methods in enzymology on CD-ROM/Methods in enzymology. 272. 177–186. 8 indexed citations

Gram, Lars F., Kim Brøsen, Søren H. Sindrup, & Erik Skjelbo. (1993). Risk factors in elderly taking psychotropic drugs: Significance of genetic polymorphism in drug oxidation. Nordic Journal of Psychiatry. 47(sup28). 85–89.

Brøsen, Kim, Søren H. Sindrup, Erik Skjelbo, Karin Kramer Nielsen, & L. F. Gram. (1993). Role of Genetic Polymorphism in Psychopharmacology — An Update. PubMed. 10. 199–211. 22 indexed citations

10.

Brøsen, Kim, Erik Skjelbo, Birgitte Buur Rasmussen, Henrik E. Poulsen, & Steffen Loft. (1993). Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochemical Pharmacology. 45(6). 1211–1214. 310 indexed citations

11.

Skjelbo, Erik, L. F. Gram, & Kim Brøsen. (1993). The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.. PubMed. 35(3). 331–4. 24 indexed citations

12.

Brøsen, Kim, Erik Skjelbo, & Helga Flachs. (1993). Proguanil metabolism is determined by the mephenytoin oxidation polymorphism in Vietnamese living in Denmark.. British Journal of Clinical Pharmacology. 36(2). 105–108. 35 indexed citations

13.

Skjelbo, Erik & Kim Brøsen. (1992). Inhibitors of imipramine metabolism by human liver microsomes.. British Journal of Clinical Pharmacology. 34(3). 256–261. 142 indexed citations

14.

Sindrup, Søren H., Kim Brøsen, Lars F. Gram, et al.. (1992). The relationship between paroxetine and the sparteine oxidation polymorphism. Clinical Pharmacology & Therapeutics. 51(3). 278–287. 173 indexed citations

15.

Brøsen, Kim, L. F. Gram, Søren H. Sindrup, Erik Skjelbo, & Karin Kramer Nielsen. (1992). PHARMACOGENETICS OF TRICYCLIC AND NOVEL ANTIDEPRESSANTS: RECENT DEVELOPMENTS. Clinical Neuropharmacology. 15. 80A–81A. 17 indexed citations

16.

Ward, Stephen A., Nuala A. Helsby, Erik Skjelbo, et al.. (1991). The activation of the biguanide antimalarial proguanil co‐segregates with the mephenytoin oxidation polymorphism‐a panel study.. British Journal of Clinical Pharmacology. 31(6). 689–692. 133 indexed citations

17.

Skjelbo, Erik, Kim Brøsen, Jesper Hallas, & Lars F. Gram. (1991). The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine. Clinical Pharmacology & Therapeutics. 49(1). 18–23. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact